A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death

Z. Bognár, T. Kalai, Anita Palfi, Katalin Hanto, Balazs Bognar, L. Márk, Zoltan Szabo, Antal Tapodi, Balazs Radnai, Zsolt Sarszegi, Arpad Szanto, F. Gallyas, K. Hideg, B. Sümegi, Gabor Varbiro

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

In ischemia-reperfusion injuries, elevated calcium and reactive oxygen species (ROS) induce mitochondrial permeability transition (mPT), which plays a pivotal role in mediating damages and cell death. Inhibition of mPT decreases necrotic cell death; however, during reperfusion, the continuous production of ROS may contribute to the temporary opening of the pore and thus the onset of the delayed apoptotic cell death. Based on amiodarone structure, we developed the first SOD-mimetic mPT inhibitor (HO-3538) that can eliminate ROS in the microenvironment of the permeability pore. In isolated mitochondria, HO-3538 inhibited mPT and the release of proapoptotic mitochondrial proteins. It had a ROS scavenging effect and antiapoptotic effect in a cardiomyocyte line and it diminished release of mitochondrial proapoptotic proteins. Furthermore, HO-3538 significantly enhanced the recovery of mitochondrial energy metabolism and functional cardiac parameters; decreased infarct size, lipid peroxidation, and protein oxidation; and suppressed necrotic as well as apoptotic cell death pathways in Langendorff-perfused hearts. In these respects it was somewhat superior to its two constituents, amiodarone and a pyrrol-derivative free radical scavenger. These data suggest that the SOD-mimetic mPT inhibitors are ideal candidates for drug development for the alleviation of postinfarct myocardial injuries.

Original languageEnglish
Pages (from-to)835-848
Number of pages14
JournalFree Radical Biology and Medicine
Volume41
Issue number5
DOIs
Publication statusPublished - Sep 1 2006

Fingerprint

Cell death
Permeability
Reactive Oxygen Species
Cell Death
Amiodarone
Mitochondrial Proteins
Free Radical Scavengers
Mitochondria
Scavenging
Proteins
Calcium
Reperfusion Injury
Derivatives
Lipids
Cardiac Myocytes
Recovery
Oxidation
Energy Metabolism
Lipid Peroxidation
Reperfusion

Keywords

  • apoptosis
  • Ischemia-reperfusion
  • Langendorff-perfused hearts
  • Mitochondrial permeability transition
  • necrosis
  • NMR
  • ROS

ASJC Scopus subject areas

  • Medicine(all)
  • Toxicology
  • Clinical Biochemistry

Cite this

A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death. / Bognár, Z.; Kalai, T.; Palfi, Anita; Hanto, Katalin; Bognar, Balazs; Márk, L.; Szabo, Zoltan; Tapodi, Antal; Radnai, Balazs; Sarszegi, Zsolt; Szanto, Arpad; Gallyas, F.; Hideg, K.; Sümegi, B.; Varbiro, Gabor.

In: Free Radical Biology and Medicine, Vol. 41, No. 5, 01.09.2006, p. 835-848.

Research output: Contribution to journalArticle

Bognár, Z. ; Kalai, T. ; Palfi, Anita ; Hanto, Katalin ; Bognar, Balazs ; Márk, L. ; Szabo, Zoltan ; Tapodi, Antal ; Radnai, Balazs ; Sarszegi, Zsolt ; Szanto, Arpad ; Gallyas, F. ; Hideg, K. ; Sümegi, B. ; Varbiro, Gabor. / A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death. In: Free Radical Biology and Medicine. 2006 ; Vol. 41, No. 5. pp. 835-848.
@article{ebdb852e93d94c78978858fb0b029075,
title = "A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death",
abstract = "In ischemia-reperfusion injuries, elevated calcium and reactive oxygen species (ROS) induce mitochondrial permeability transition (mPT), which plays a pivotal role in mediating damages and cell death. Inhibition of mPT decreases necrotic cell death; however, during reperfusion, the continuous production of ROS may contribute to the temporary opening of the pore and thus the onset of the delayed apoptotic cell death. Based on amiodarone structure, we developed the first SOD-mimetic mPT inhibitor (HO-3538) that can eliminate ROS in the microenvironment of the permeability pore. In isolated mitochondria, HO-3538 inhibited mPT and the release of proapoptotic mitochondrial proteins. It had a ROS scavenging effect and antiapoptotic effect in a cardiomyocyte line and it diminished release of mitochondrial proapoptotic proteins. Furthermore, HO-3538 significantly enhanced the recovery of mitochondrial energy metabolism and functional cardiac parameters; decreased infarct size, lipid peroxidation, and protein oxidation; and suppressed necrotic as well as apoptotic cell death pathways in Langendorff-perfused hearts. In these respects it was somewhat superior to its two constituents, amiodarone and a pyrrol-derivative free radical scavenger. These data suggest that the SOD-mimetic mPT inhibitors are ideal candidates for drug development for the alleviation of postinfarct myocardial injuries.",
keywords = "apoptosis, Ischemia-reperfusion, Langendorff-perfused hearts, Mitochondrial permeability transition, necrosis, NMR, ROS",
author = "Z. Bogn{\'a}r and T. Kalai and Anita Palfi and Katalin Hanto and Balazs Bognar and L. M{\'a}rk and Zoltan Szabo and Antal Tapodi and Balazs Radnai and Zsolt Sarszegi and Arpad Szanto and F. Gallyas and K. Hideg and B. S{\"u}megi and Gabor Varbiro",
year = "2006",
month = "9",
day = "1",
doi = "10.1016/j.freeradbiomed.2006.06.004",
language = "English",
volume = "41",
pages = "835--848",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death

AU - Bognár, Z.

AU - Kalai, T.

AU - Palfi, Anita

AU - Hanto, Katalin

AU - Bognar, Balazs

AU - Márk, L.

AU - Szabo, Zoltan

AU - Tapodi, Antal

AU - Radnai, Balazs

AU - Sarszegi, Zsolt

AU - Szanto, Arpad

AU - Gallyas, F.

AU - Hideg, K.

AU - Sümegi, B.

AU - Varbiro, Gabor

PY - 2006/9/1

Y1 - 2006/9/1

N2 - In ischemia-reperfusion injuries, elevated calcium and reactive oxygen species (ROS) induce mitochondrial permeability transition (mPT), which plays a pivotal role in mediating damages and cell death. Inhibition of mPT decreases necrotic cell death; however, during reperfusion, the continuous production of ROS may contribute to the temporary opening of the pore and thus the onset of the delayed apoptotic cell death. Based on amiodarone structure, we developed the first SOD-mimetic mPT inhibitor (HO-3538) that can eliminate ROS in the microenvironment of the permeability pore. In isolated mitochondria, HO-3538 inhibited mPT and the release of proapoptotic mitochondrial proteins. It had a ROS scavenging effect and antiapoptotic effect in a cardiomyocyte line and it diminished release of mitochondrial proapoptotic proteins. Furthermore, HO-3538 significantly enhanced the recovery of mitochondrial energy metabolism and functional cardiac parameters; decreased infarct size, lipid peroxidation, and protein oxidation; and suppressed necrotic as well as apoptotic cell death pathways in Langendorff-perfused hearts. In these respects it was somewhat superior to its two constituents, amiodarone and a pyrrol-derivative free radical scavenger. These data suggest that the SOD-mimetic mPT inhibitors are ideal candidates for drug development for the alleviation of postinfarct myocardial injuries.

AB - In ischemia-reperfusion injuries, elevated calcium and reactive oxygen species (ROS) induce mitochondrial permeability transition (mPT), which plays a pivotal role in mediating damages and cell death. Inhibition of mPT decreases necrotic cell death; however, during reperfusion, the continuous production of ROS may contribute to the temporary opening of the pore and thus the onset of the delayed apoptotic cell death. Based on amiodarone structure, we developed the first SOD-mimetic mPT inhibitor (HO-3538) that can eliminate ROS in the microenvironment of the permeability pore. In isolated mitochondria, HO-3538 inhibited mPT and the release of proapoptotic mitochondrial proteins. It had a ROS scavenging effect and antiapoptotic effect in a cardiomyocyte line and it diminished release of mitochondrial proapoptotic proteins. Furthermore, HO-3538 significantly enhanced the recovery of mitochondrial energy metabolism and functional cardiac parameters; decreased infarct size, lipid peroxidation, and protein oxidation; and suppressed necrotic as well as apoptotic cell death pathways in Langendorff-perfused hearts. In these respects it was somewhat superior to its two constituents, amiodarone and a pyrrol-derivative free radical scavenger. These data suggest that the SOD-mimetic mPT inhibitors are ideal candidates for drug development for the alleviation of postinfarct myocardial injuries.

KW - apoptosis

KW - Ischemia-reperfusion

KW - Langendorff-perfused hearts

KW - Mitochondrial permeability transition

KW - necrosis

KW - NMR

KW - ROS

UR - http://www.scopus.com/inward/record.url?scp=33746682437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746682437&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2006.06.004

DO - 10.1016/j.freeradbiomed.2006.06.004

M3 - Article

VL - 41

SP - 835

EP - 848

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 5

ER -